Gene therapy in osteoarticular diseases: where are we?
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 19 (9) , 387-391
- https://doi.org/10.1016/s0167-5699(98)01296-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Molecular biology of cartilage and bone destructionCurrent Opinion in Rheumatology, 1998
- Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.Journal of Clinical Investigation, 1997
- Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor geneArthritis & Rheumatism, 1997
- Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis modelGene Therapy, 1997
- Biologic agents for treating rheumatoid arthritis. Concepts and progressArthritis & Rheumatism, 1997
- Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?Arthritis & Rheumatism, 1997
- Invasive fibroblast‐like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?Arthritis & Rheumatism, 1996
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- Clinical Trial to Assess the Safety, Feasibility, and Efficacy of Transferring a Potentially Anti-Arthritic Cytokine Gene to Human Joints with Rheumatoid Arthritis. University of Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaHuman Gene Therapy, 1996
- Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?Annals of the Rheumatic Diseases, 1993